Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
European Urology Oncology|June 21, 2024
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline PanelsLaura S Mertens, Harman Maxim Bruins, Roberto Contieri, et al.
BJU International|February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomyFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Clinical Genitourinary Cancer|November 12, 2013
Nephron-sparing surgery for renal tumors measuring more than 7 cm: morbidity, and functional and oncological outcomesPierre Bigot, Jean-François Hétet, Jean-Christophe Bernhard, et al.
European Urology Oncology|May 26, 2026
Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development ProcessElke Rammant, Louis Fox, Silva De Padova, et al.
European Urology|July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>†</sup>Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
Urologic Oncology|December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patientsLaura S Mertens, Francesco Claps, Roman Mayr, et al.
Annals of Surgical Oncology|October 31, 2013
Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French studyGéraldine Pignot, Laurent Salomon, Yann Neuzillet, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
European Urology|November 23, 2019
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>†</sup>: Under the Auspices of the EAU-ESMO Guidelines CommitteesJ Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, et al.
Pageof 15